Novo Nordisk: Six Analyses of Drug Development and Digital Investment

How do medicines, devices, evidence and digital support combine to create and capture value?

The Novo Nordisk Business Model Canvas examines all nine building blocks: customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partnerships and cost structure. For this business, the connections matter. A treatment may reach patients through healthcare professionals and health systems, while clinical evidence, device design, manufacturing capabilities and digital partners affect the delivered experience. The canvas helps map those dependencies without assuming that every proposed relationship or revenue source is already established.

• Care ecosystem. Explore how patients, clinicians, payers and healthcare providers can shape access, support and treatment continuity.
• Value architecture. Link medicines and injection devices with evidence generation, research, manufacturing, partnerships and associated cost commitments.
• Model mapping. Populate the Excel canvas systematically, then use the Word analysis to examine tensions between patient value, channel needs and economics.

How can a regulated healthcare offering be considered through product, price, place and promotion?

The Novo Nordisk Marketing Mix applies the 4Ps to a healthcare setting where clinical utility, patient experience and access pathways all matter. Product can include therapies, delivery devices and potential digital companions. Price is not simply a consumer shelf decision; it raises questions about value evidence, reimbursement and affordability. Place concerns routes through healthcare providers, pharmacies and care systems, while promotion must be considered in the context of professional education, scientific communication and applicable regulations.

• Integrated product. Examine how treatment, injection delivery and adherence support may contribute to a coherent patient proposition.
• Responsible reach. Compare channel and communication choices for clinicians, healthcare organisations and patients without assuming a specific campaign or price.
• 4P planning aid. Use the Excel structure to separate each marketing decision, then consult the Word analysis for the healthcare trade-offs behind them.

How can internal capabilities be weighed against external opportunities and risks in connected healthcare?

A Novo Nordisk SWOT analysis helps keep internal and external considerations correctly separated. Strengths and weaknesses concern capabilities and constraints inside the business, such as scientific expertise, treatment-delivery know-how, operating resources or organisational dependencies that merit examination. Opportunities and threats arise outside the company, including changing care needs, technology partnerships, policy conditions and competitive dynamics. The framework is useful because it can connect a possible internal capability to a specific market condition without claiming that a plausible theme has already been proven.

• Internal reality. Consider which scientific, clinical, manufacturing and patient-support capabilities may be relevant strengths or potential limitations to investigate.
• External fit. Relate healthcare demand, digital-care developments and access pressures to opportunities or threats rather than misclassifying them as internal factors.
• Decision preparation. Use the Excel grid to sort evidence by category, then use the Word analysis to develop balanced capability-to-condition comparisons.